STARJEMZA Trademark

Trademark Overview


On Friday, August 18, 2023, a trademark application was filed for STARJEMZA with the United States Patent and Trademark Office. The USPTO has given the STARJEMZA trademark a serial number of 98140111. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, December 11, 2024. This trademark is owned by Hikma Pharmaceuticals USA Inc.. The STARJEMZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune disorders, excluding chronic hand eczema; pharmaceutical preparations for the treatment of psoriasis, psoriatic arthritis, Crohn's disease or ulcerative colitis.
starjemza

General Information


Serial Number98140111
Word MarkSTARJEMZA
Filing DateFriday, August 18, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, December 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 30, 2024

Trademark Statements


Description of MarkThe mark consists of the word "Starjemza" in blue font. The dot on the letter "j" is orange and has five orange lines emanating from it.
Goods and ServicesPharmaceutical preparations for the treatment of autoimmune disorders, excluding chronic hand eczema; pharmaceutical preparations for the treatment of psoriasis, psoriatic arthritis, Crohn's disease or ulcerative colitis.
Indication of Colors claimedThe color(s) blue and orange is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 18, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHikma Pharmaceuticals USA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922

Party NameHikma Pharmaceuticals USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922

Trademark Events


Event DateEvent Description
Tuesday, August 22, 2023NEW APPLICATION ENTERED
Friday, March 22, 2024ASSIGNED TO EXAMINER
Wednesday, April 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 24, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, September 18, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 19, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, March 24, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, June 15, 2024POST PUBLICATION AMENDMENT - ENTERED
Thursday, June 6, 2024ASSIGNED TO PETITION STAFF
Friday, June 14, 2024POST PUBLICATION AMENDMENT - ENTERED
Tuesday, June 25, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, December 11, 2024SOU EXTENSION 1 FILED
Thursday, December 12, 2024SOU EXTENSION 1 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED